26 October 2021 Quanta Therapeutics Announces Oversubscribed $60 Million Series C Financing to Advance Novel RAS-targeting Programs read more
21 October 2021 ReCode Therapeutics Raises Oversubscribed Series B Financing Round of $80 Million read more
9 September 2021 Centessa Pharmaceuticals Announces Positive Topline Data from Proof-of-Concept Study of SerpinPC in Severe Hemophilia A and B Patients Not on Prophylaxis read more
18 August 2021 Vigil Neuroscience Completes $90 million Series B Financing to Advance a Pipeline of Microglia-targeted Medicines to Treat Rare and Common Neurodegenerative Diseases read more
24 June 2021 Vida Ventures Closes $825 Million Vida III Fund to Advance Transformative Biomedical Innovations read more
